Zurcher Kantonalbank (Zurich Cantonalbank) Novavax Inc Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Novavax Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 94,218 shares of NVAX stock, worth $868,689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,218
Previous 94,218
-0.0%
Holding current value
$868,689
Previous $603,000
1.66%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding NVAX
# of Institutions
315Shares Held
94.7MCall Options Held
6.11MPut Options Held
10.5M-
Vanguard Group Inc Valley Forge, PA15.4MShares$142 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$109 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$106 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$62.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$36.3 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $721M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...